SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-021730
Filing Date
2022-02-14
Accepted
2022-02-14 08:35:12
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G tm222623d53_sc13g.htm SC 13G 51274
  Complete submission text file 0001104659-22-021730.txt   52830
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Subject) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92874 | Film No.: 22625640
SIC: 2834 Pharmaceutical Preparations